Table 1. Baseline characteristics of the three study groups.
| Variable | HIV+ART+ N = 28 |
HIV+ART- N = 44 |
HIV- N = 39 |
p-value |
|---|---|---|---|---|
| Male sex, n (%) | 26 (93) | 35 (80) | 32 (82) | 0.36 |
| Black race, n (%) | 17 (61) | 27 (61) | 13 (33) | 0.02 |
| Current smoker, n (%) | 16 (57) | 22 (50) | 21 (54) | 0.76 |
| Age, years (SD) | 37.7 (11.5) | 36.6 (10.9) | 37.5 (11.6) | 0.90 |
| Height, m (SD) | 1.77 (0.07) | 1.75 (0.10) | 1.75 (0.08) | 0.56 |
| Weight, kg (SD) | 85.42 (17.21) | 81.05 (16.31) | 83.94 (15.41) | 0.58 |
| BMI, kg/m2 (SD) | 27.28 (5.11) | 26.50 (5.13) | 27.69 (5.82) | 0.63 |
| Systolic blood pressure, mm Hg (SD) | 125.73 (12.05) | 117.51 (15.02) | 121.40 (15.07) | 0.07 |
| Diastolic blood pressure, mm Hg (SD) | 79.20 (8.55) | 71.77 (8.55) | 72.88 (9.11) | <0.01 |
| CD4 cell count/μL (SD) | 683 (361) | 421 (243) | 964 (377) | <0.01 |
| HIV RNA level, log10copies/mL (SD) | 1.46 (1.33) | 5.17 (5.43) | — | <0.01 |
Note: Data presented as number (%) or mean (standard deviation)
ART, antiretroviral therapy; BMI, body mass index